Verastem (VSTM) Change in Receivables (2018 - 2026)
Verastem (VSTM) posted quarterly Change in Receivables of $1.3 million for Q1 2026, down 35.86% quarter-over-quarter from $2.1 million in Q4 2025.
Analysis
Verastem (VSTM) Change in Receivables (2018 - 2026) Analysis & Trends
Verastem's Change in Receivables history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Change in Receivables changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $8.1 million (changed N/A YoY), while the FY2025 annual figure was $8.8 million, changed N/A from the prior year.
- Change in Receivables for Q1 2026 stood at $1.3 million, down from $2.1 million in the prior quarter.
- The five-year high for Change in Receivables was $4.6 million in Q3 2025, with the low at -$2.5 million in Q2 2022.
- The 4-year median for Change in Receivables is $0.0 (2023), against an average of $756600.0.
- Peak annual rise in Change in Receivables reached 140.18% in 2022, while the deepest fall reached 287.21% in 2022.
- Verastem's Change in Receivables stood at -$43000.0 in 2022, then soared by 95.35% to -$2000.0 in 2023, then surged by 104950.0% to $2.1 million in 2025, then plunged by 35.86% to $1.3 million in 2026.
- Business Quant data shows VSTM's Change in Receivables at $1.3 million in Q1 2026, $2.1 million in Q4 2025, and $4.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn | 18.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.72 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Dec 31, 2022 | -43,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Dec 31, 2021 | 411,000.00 |
| Sep 30, 2021 | -371,000.00 |
| Jun 30, 2021 | -649,000.00 |
| Mar 31, 2021 | 886,000.00 |
| Dec 31, 2020 | -5.45 Mn |
| Sep 30, 2020 | 4.19 Mn |
| Jun 30, 2020 | -1.83 Mn |
| Mar 31, 2020 | 802,000.00 |
| Dec 31, 2019 | 321,000.00 |